UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G/A
Under the Securities Exchange Act of 1934
(Amendment No. 1 – Exit Filing)*
Quanterix Corporation
(Name of Issuer)
Common Stock
(Title of Class of Securities)
74766Q101
(CUSIP Number)
November 7, 2019
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☐ Rule 13d-1(c)
☒ Rule 13d-1(d)
| * | The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. |
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes).
| CUSIP No. 74766Q101 |
| 1 | NAMES OF REPORTING PERSONS
bioMérieux SA | |||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) ☐ (b) ☐ | |||||
| 3 | SEC USE ONLY
| |||||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION
France | |||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 | SOLE VOTING POWER
0 | ||||
| 6 | SHARED VOTING POWER
0 | |||||
| 7 | SOLE DISPOSITIVE POWER
0 | |||||
| 8 | SHARED DISPOSITIVE POWER
0 | |||||
| 9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0 | |||||
| 10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
☐ | |||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0% | |||||
| 12 | TYPE OF REPORTING PERSON*
CO | |||||
| Item 1(a). | Name of Issuer |
Quanterix Corporation (the “Issuer”).
| Item 1(b). | Address of Issuer’s Principal Executive Offices |
900 Middlesex Turnpike
Billerica, MA 01821
| Item 2(a). | Name of Person Filing |
bioMérieux SA
| Item 2(b). | Address of Principal Business Office or, if none, Residence |
376 Chemin de l’Orme, 69280 Marcy l’Étoile, France
| Item 2(c). | Citizenship |
France
| Item 2(d). | Title of Class of Securities |
Common stock, par value $0.001 per share.
| Item 2(e). | CUSIP Number |
74766Q101.
| Item 3. | If This Statement Is Filed Pursuant to Sections 240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing Is a(n): |
Not Applicable.
| Item 4. | Ownership |
| (a) | Amount beneficially owned: |
| 0 shares of Common Stock. |
| (b) | Percent of class: |
| 0% |
| (c) | Number of shares as to which such person has: |
| (i) | Sole power to vote or to direct the vote: |
| 0 |
| (ii) | Shared power to vote or to direct the vote: |
| 0 |
| (iii) | Sole power to dispose or to direct the disposition: |
| 0 |
| (iv) | Shared power to dispose or to direct the disposition: |
| 0 |
| Item 5. | Ownership of Five Percent or Less of a Class |
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following: ☒
| Item 6. | Ownership of More Than Five Percent on Behalf of Another Person |
Not Applicable.
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company |
Not Applicable.
| Item 8. | Identification and Classification of Members of the Group |
Not Applicable.
| Item 9. | Notice of Dissolution of Group |
Not Applicable.
| Item 10. | Certifications |
Not Applicable.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: November 18, 2019
| BIOMÉRIEUX SA | ||||
| By | /s/ Alexandre Mérieux | |||
| Name: | Alexandre Mérieux | |||
| Title: | Chief Executive Officer | |||